IBB Holdings — iShares Biotechnology ETF
All 251 reported holdings of iShares Biotechnology ETF (IBB) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| BlackRock Funds III | 11.66% | $1.06B |
| Vertex Pharmaceuticals, Inc. | 8.08% | $734.32M |
| Amgen, Inc. | 7.83% | $711.36M |
| Gilead Sciences, Inc. | 6.84% | $621.79M |
| Regeneron Pharmaceuticals, Inc. | 4.91% | $445.87M |
| Argenx SE | 3.76% | $341.58M |
| Alnylam Pharmaceuticals, Inc. | 3.12% | $283.62M |
| Natera, Inc. | 2.89% | $262.68M |
| Revolution Medicines, Inc. | 2.78% | $252.66M |
| Biogen, Inc. | 2.47% | $224.09M |
| Illumina, Inc. | 2.07% | $188.03M |
| Moderna, Inc. | 1.98% | $180.31M |
| Insmed, Inc. | 1.78% | $162.20M |
| BeOne Medicines Ltd. | 1.77% | $160.77M |
| Incyte Corp. | 1.75% | $159.00M |
| United Therapeutics Corp. | 1.73% | $157.56M |
| Roivant Sciences Ltd. | 1.43% | $129.59M |
| Neurocrine Biosciences, Inc. | 1.30% | $117.98M |
| Ascendis Pharma A/S | 1.29% | $116.86M |
| Genmab A/S | 1.12% | $101.67M |
| Exelixis, Inc. | 1.03% | $93.91M |
| Ionis Pharmaceuticals, Inc. | 1.00% | $91.06M |
| Bridgebio Pharma, Inc. | 0.98% | $89.23M |
| Medpace Holdings, Inc. | 0.95% | $86.35M |
| Madrigal Pharmaceuticals, Inc. | 0.91% | $82.55M |
| Bio-Techne Corp. | 0.86% | $78.10M |
| BioMarin Pharmaceutical, Inc. | 0.85% | $77.17M |
| Charles River Laboratories International, Inc. | 0.84% | $76.49M |
| Arrowhead Pharmaceuticals, Inc. | 0.84% | $76.43M |
| Axsome Therapeutics, Inc. | 0.82% | $74.69M |
| Cytokinetics, Inc. | 0.79% | $71.93M |
| Krystal Biotech, Inc. | 0.75% | $67.75M |
| Halozyme Therapeutics, Inc. | 0.72% | $65.11M |
| Praxis Precision Medicines, Inc. | 0.68% | $61.94M |
| Abivax SA | 0.67% | $61.14M |
| Alkermes plc | 0.67% | $60.51M |
| BioNTech SE | 0.66% | $60.22M |
| Vaxcyte, Inc. | 0.64% | $58.16M |
| Kymera Therapeutics, Inc. | 0.64% | $57.80M |
| Apogee Therapeutics, Inc. | 0.59% | $53.58M |
| Protagonist Therapeutics, Inc. | 0.58% | $53.00M |
| Rhythm Pharmaceuticals, Inc. | 0.57% | $52.22M |
| Repligen Corp. | 0.57% | $51.60M |
| Spyre Therapeutics, Inc. | 0.54% | $48.62M |
| Bruker Corp. | 0.52% | $47.39M |
| PTC Therapeutics, Inc. | 0.51% | $46.32M |
| Nuvalent, Inc. | 0.50% | $45.70M |
| Twist Bioscience Corp. | 0.48% | $43.45M |
| Tempus AI, Inc. | 0.48% | $43.37M |
| Mirum Pharmaceuticals, Inc. | 0.45% | $41.14M |
| Cogent Biosciences, Inc. | 0.44% | $40.35M |
| Xenon Pharmaceuticals, Inc. | 0.43% | $38.81M |
| Scholar Rock Holding Corp. | 0.41% | $37.59M |
| Travere Therapeutics, Inc. | 0.40% | $36.38M |
| Definium Therapeutics, Inc. | 0.38% | $34.97M |
| CRISPR Therapeutics AG | 0.38% | $34.61M |
| BlackRock Funds III | 0.38% | $34.26M |
| Oruka Therapeutics, Inc. | 0.38% | $34.19M |
| Veracyte, Inc. | 0.36% | $32.38M |
| 10X Genomics, Inc. | 0.34% | $30.65M |
| Legend Biotech Corp. | 0.33% | $30.40M |
| ACADIA Pharmaceuticals, Inc. | 0.33% | $30.26M |
| CG oncology, Inc. | 0.32% | $28.94M |
| Denali Therapeutics, Inc. | 0.30% | $27.11M |
| Crinetics Pharmaceuticals, Inc. | 0.29% | $25.90M |
| Erasca, Inc. | 0.27% | $24.28M |
| Tango Therapeutics, Inc. | 0.26% | $23.49M |
| Adaptive Biotechnologies Corp. | 0.26% | $23.48M |
| ImmunityBio, Inc. | 0.26% | $23.34M |
| Beam Therapeutics, Inc. | 0.25% | $22.80M |
| Edgewise Therapeutics, Inc. | 0.25% | $22.59M |
| Structure Therapeutics, Inc. | 0.24% | $22.23M |
| Immunovant, Inc. | 0.24% | $22.11M |
| Ideaya Biosciences, Inc. | 0.24% | $21.94M |
| Ultragenyx Pharmaceutical, Inc. | 0.23% | $21.21M |
| Dyne Therapeutics, Inc. | 0.23% | $20.78M |
| Arcutis Biotherapeutics, Inc. | 0.23% | $20.52M |
| GRAIL, Inc. | 0.21% | $19.18M |
| Newamsterdam Pharma Co. NV | 0.21% | $19.19M |
| Relay Therapeutics, Inc. | 0.21% | $19.01M |
| uniQure NV | 0.20% | $18.39M |
| Arcus Biosciences, Inc. | 0.20% | $18.29M |
| Tarsus Pharmaceuticals, Inc. | 0.20% | $18.01M |
| Vera Therapeutics, Inc. | 0.20% | $17.79M |
| Enliven Therapeutics, Inc. | 0.19% | $16.91M |
| Nurix Therapeutics, Inc. | 0.19% | $16.87M |
| Alumis, Inc. | 0.18% | $16.72M |
| Kodiak Sciences, Inc. | 0.18% | $15.99M |
| Vericel Corp. | 0.18% | $15.93M |
| Intellia Therapeutics, Inc. | 0.17% | $15.88M |
| Caris Life Sciences, Inc. | 0.17% | $15.49M |
| BioCryst Pharmaceuticals, Inc. | 0.17% | $15.29M |
| Agios Pharmaceuticals, Inc. | 0.16% | $14.68M |
| Disc Medicine, Inc. | 0.16% | $14.35M |
| Summit Therapeutics, Inc. | 0.15% | $13.93M |
| Aurinia Pharmaceuticals, Inc. | 0.15% | $13.59M |
| ADMA Biologics, Inc. | 0.15% | $13.38M |
| Biohaven Ltd. | 0.15% | $13.25M |
| Zymeworks, Inc. | 0.14% | $13.08M |
| AnaptysBio, Inc. | 0.14% | $13.06M |
| AbCellera Biologics, Inc. | 0.14% | $13.00M |
| Sarepta Therapeutics, Inc. | 0.14% | $12.92M |
| Syndax Pharmaceuticals, Inc. | 0.14% | $12.50M |
| Trevi Therapeutics, Inc. | 0.14% | $12.27M |
| Recursion Pharmaceuticals, Inc. | 0.13% | $12.25M |
| Zai Lab Ltd. | 0.13% | $12.04M |
| Amylyx Pharmaceuticals, Inc. | 0.13% | $11.83M |
| Mineralys Therapeutics, Inc. | 0.13% | $11.64M |
| Fortrea Holdings, Inc. | 0.13% | $11.55M |
| Taysha Gene Therapies, Inc. | 0.13% | $11.49M |
| MBX Biosciences, Inc. | 0.13% | $11.47M |
| Stoke Therapeutics, Inc. | 0.13% | $11.45M |
| Iovance Biotherapeutics, Inc. | 0.13% | $11.39M |
| Novocure Ltd. | 0.12% | $11.13M |
| Grifols SA | 0.12% | $11.00M |
| AtaiBeckley, Inc. | 0.12% | $10.93M |
| Absci Corp. | 0.12% | $10.92M |
| Compass Pathways plc | 0.12% | $10.82M |
| UroGen Pharma Ltd. | 0.12% | $10.69M |
| Novavax, Inc. | 0.12% | $10.46M |
| Monte Rosa Therapeutics, Inc. | 0.11% | $10.04M |
| Tyra Biosciences, Inc. | 0.11% | $10.05M |
| Nuvation Bio, Inc. | 0.11% | $9.90M |
| Vir Biotechnology, Inc. | 0.11% | $9.67M |
| Immunocore Holdings plc | 0.10% | $9.50M |
| CareDx, Inc. | 0.10% | $9.38M |
| GH Research plc | 0.10% | $9.30M |
| MannKind Corp. | 0.10% | $8.85M |
| Lakefront Biotherapeutics NV | 0.10% | $8.77M |
| Rapport Therapeutics, Inc. | 0.09% | $8.36M |
| Sionna Therapeutics, Inc. | 0.09% | $8.17M |
| ArriVent Biopharma, Inc. | 0.09% | $8.01M |
| Xencor, Inc. | 0.09% | $7.94M |
| Bicara Therapeutics, Inc. | 0.09% | $7.87M |
| Inhibrx Biosciences, Inc. | 0.08% | $7.26M |
| Maze Therapeutics, Inc. | 0.08% | $7.24M |
| Pharvaris NV | 0.08% | $7.17M |
| WaVe Life Sciences Ltd. | 0.08% | $6.93M |
| Stevanato Group SpA | 0.07% | $6.74M |
| Mesoblast Ltd. | 0.07% | $6.70M |
| MeiraGTx Holdings plc | 0.07% | $6.68M |
| Corvus Pharmaceuticals, Inc. | 0.07% | $6.66M |
| Kura Oncology, Inc. | 0.07% | $6.65M |
| Septerna, Inc. | 0.07% | $6.45M |
| Precigen, Inc. | 0.07% | $6.37M |
| Olema Pharmaceuticals, Inc. | 0.07% | $6.23M |
| Janux Therapeutics, Inc. | 0.07% | $6.20M |
| Replimune Group, Inc. | 0.07% | $5.95M |
| Zevra Therapeutics, Inc. | 0.07% | $5.90M |
| Personalis, Inc. | 0.06% | $5.86M |
| Alto Neuroscience, Inc. | 0.06% | $5.85M |
| Cullinan Therapeutics, Inc. | 0.06% | $5.81M |
| Theravance Biopharma, Inc. | 0.06% | $5.79M |
| Annexon, Inc. | 0.06% | $5.76M |
| Zenas Biopharma, Inc. | 0.06% | $5.70M |
| Geron Corp. | 0.06% | $5.67M |
| Solid Biosciences, Inc. | 0.06% | $5.51M |
| BioAge Labs, Inc. | 0.06% | $5.47M |
| Arbutus Biopharma Corp. | 0.06% | $5.32M |
| Castle Biosciences, Inc. | 0.05% | $4.97M |
| Rigel Pharmaceuticals, Inc. | 0.05% | $4.94M |
| Ironwood Pharmaceuticals, Inc. | 0.05% | $4.70M |
| ORIC Pharmaceuticals, Inc. | 0.05% | $4.66M |
| Savara, Inc. | 0.05% | $4.63M |
| Maravai LifeSciences Holdings, Inc. | 0.05% | $4.63M |
| Sana Biotechnology, Inc. | 0.05% | $4.46M |
| CytomX Therapeutics, Inc. | 0.05% | $4.42M |
| 4D Molecular Therapeutics, Inc. | 0.05% | $4.38M |
| Phathom Pharmaceuticals, Inc. | 0.05% | $4.36M |
| Candel Therapeutics, Inc. | 0.05% | $4.23M |
| Aclaris Therapeutics, Inc. | 0.05% | $4.12M |
| REGENXBIO, Inc. | 0.04% | $4.03M |
| OPKO Health, Inc. | 0.04% | $3.99M |
| Altimmune, Inc. | 0.04% | $3.94M |
| Design Therapeutics, Inc. | 0.04% | $3.85M |
| Allogene Therapeutics, Inc. | 0.04% | $3.75M |
| Cytek Biosciences, Inc. | 0.04% | $3.69M |
| Myriad Genetics, Inc. | 0.04% | $3.56M |
| ARS Pharmaceuticals, Inc. | 0.04% | $3.54M |
| Ginkgo Bioworks Holdings, Inc. | 0.04% | $3.53M |
| Contineum Therapeutics, Inc. | 0.04% | $3.36M |
| Pacific Biosciences of California, Inc. | 0.04% | $3.35M |
| C4 Therapeutics, Inc. | 0.04% | $3.30M |
| Aura Biosciences, Inc. | 0.04% | $3.24M |
| Sagimet Biosciences, Inc. | 0.04% | $3.20M |
| Arvinas, Inc. | 0.04% | $3.19M |
| Cabaletta Bio, Inc. | 0.03% | $3.13M |
| Prothena Corp. plc | 0.03% | $3.12M |
| Alvotech SA | 0.03% | $3.10M |
| Emergent BioSolutions, Inc. | 0.03% | $2.88M |
| Enanta Pharmaceuticals, Inc. | 0.03% | $2.84M |
| Neurogene, Inc. | 0.03% | $2.78M |
| Fulgent Genetics, Inc. | 0.03% | $2.65M |
| Rocket Pharmaceuticals, Inc. | 0.03% | $2.50M |
| Prime Medicine, Inc. | 0.03% | $2.47M |
| Vanda Pharmaceuticals, Inc. | 0.03% | $2.46M |
| Kyverna Therapeutics, Inc. | 0.03% | $2.37M |
| BridgeBio Oncology Therapeutics, Inc. | 0.03% | $2.33M |
| Autolus Therapeutics plc | 0.03% | $2.29M |
| Tectonic Therapeutic, Inc. | 0.03% | $2.29M |
| Editas Medicine, Inc. | 0.02% | $2.23M |
| Standard BioTools, Inc. | 0.02% | $2.18M |
| Perspective Therapeutics, Inc. | 0.02% | $2.17M |
| Silence Therapeutics plc | 0.02% | $2.04M |
| OmniAb, Inc. | 0.02% | $2.04M |
| Atea Pharmaceuticals, Inc. | 0.02% | $2.04M |
| Lexeo Therapeutics, Inc. | 0.02% | $2.03M |
| Immuneering Corp. | 0.02% | $1.93M |
| Upstream Bio, Inc. | 0.02% | $1.77M |
| Lineage Cell Therapeutics, Inc. | 0.02% | $1.73M |
| Anavex Life Sciences Corp. | 0.02% | $1.64M |
| Fulcrum Therapeutics, Inc. | 0.02% | $1.46M |
| Keros Therapeutics, Inc. | 0.02% | $1.37M |
| Codexis, Inc. | 0.01% | $1.34M |
| Arcturus Therapeutics Holdings, Inc. | 0.01% | $1.23M |
| Voyager Therapeutics, Inc. | 0.01% | $1.22M |
| Quanterix Corp. | 0.01% | $1.21M |
| NovaBridge Biosciences | 0.01% | $1.15M |
| Humacyte, Inc. | 0.01% | $1.12M |
| Larimar Therapeutics, Inc. | 0.01% | $1.13M |
| Pyxis Oncology, Inc. | 0.01% | $1.13M |
| Entrada Therapeutics, Inc. | 0.01% | $1.11M |
| Caribou Biosciences, Inc. | 0.01% | $1.11M |
| Tenaya Therapeutics, Inc. | 0.01% | $1.10M |
| LENZ Therapeutics, Inc. | 0.01% | $1.10M |
| Foghorn Therapeutics, Inc. | 0.01% | $1.08M |
| Quantum-Si, Inc. | 0.01% | $1.06M |
| Bicycle Therapeutics plc | 0.01% | $1.03M |
| AC Immune SA | 0.01% | $1.03M |
| Neumora Therapeutics, Inc. | 0.01% | $924.06K |
| PepGen, Inc. | 0.01% | $807.33K |
| Lyell Immunopharma, Inc. | 0.01% | $759.70K |
| ADC Therapeutics SA | 0.01% | $715.77K |
| Cellectis SA | 0.01% | $669.34K |
| Black Diamond Therapeutics, Inc. | 0.01% | $642.16K |
| Aardvark Therapeutics, Inc. | 0.01% | $513.35K |
| Alpha Teknova, Inc. | 0.00% | $438.30K |
| Jyong Biotech Ltd. | 0.00% | $424.78K |
| Akero Therapeutics, Inc. | 0.00% | $335.37K |
| Immutep Ltd. | 0.00% | $305.79K |
| Gossamer Bio, Inc. | 0.00% | $247.08K |
| Contra Chinook Therape | 0.00% | $54.56K |
| Arcellx, Inc. | 0.00% | $23.51K |
| OmniAb Operations, Inc. | 0.00% | $0 |
| OmniAb, Inc. | 0.00% | $0 |
| Cartesian Therapeutics, Inc. | 0.00% | $1.87K |
| Third Harmonic Bio, Inc. | 0.00% | $1 |
| Cargo Therapeutics, Inc. | 0.00% | $2 |
| Fusion Pharmaceuticals, Inc. | 0.00% | $1.03K |
| Akouos, Inc. | 0.00% | $2 |